Chaeum Premium No. 4: Regulatory Status and Sourcing Guidelines for Professionals

Chaeum Premium No. 4 is a hyaluronic acid (HA) dermal filler manufactured by Hugel, a prominent South Korean company in the medical aesthetics sector. As part of a diverse range of HA fillers, Chaeum Premium No. 4 is formulated for professional aesthetic applications. Its origin from South Korea means its initial regulatory framework is governed by local standards, which often serve as a basis for international market acceptance. Professionals frequently evaluate various HA fillers available for their practices, exploring options such as Hyaldew or D.Fill Soft to ensure a comprehensive product portfolio.

In South Korea, medical devices like Chaeum Premium No. 4 are regulated by the Ministry of Food and Drug Safety (MFDS), formerly known as the KFDA. MFDS approval signifies that the product meets specific safety and quality standards for sale and use within South Korea. Hugel's adherence to Good Manufacturing Practices (GMP) is also crucial. GMP ensures that products are consistently produced and controlled according to quality standards. This compliance is a baseline expectation for any manufacturer seeking to distribute aesthetic injectables globally. [VERIFY: Hugel's MFDS approval and GMP certification status for Chaeum Premium No. 4 production facilities].

For market access outside South Korea, international certifications are key. The CE mark is essential for distributing medical devices within the European Union (EU) and other European Economic Area (EEA) countries, indicating conformity with health, safety, and environmental protection standards. Furthermore, ISO 13485 certification is a globally recognized standard for quality management systems specific to medical devices, demonstrating a manufacturer's commitment to quality throughout the product lifecycle. Clinics should always verify these certifications when considering new additions to their Hyaluronic acid dermal filler catalog. [VERIFY: Chaeum Premium No. 4 CE mark status for EU market entry]. [VERIFY: Hugel's ISO 13485 certification for manufacturing Chaeum Premium No. 4]. [VERIFY: Chaeum Premium No. 4 FDA approval status for the US market].

Accessing international markets like the EU, UK, GCC, Latin America (LATAM), and Asia-Pacific (APAC) involves navigating distinct regulatory pathways. While a CE mark facilitates EU distribution, individual countries within these regions often impose additional registration requirements. The UK, post-Brexit, maintains its own regulatory system (UKCA marking in some cases), though CE-marked products may still be recognized under specific agreements. GCC, LATAM, and APAC nations each have their own health authorities and import regulations, necessitating country-specific registrations and approvals before Chaeum Premium No. 4 can be legally sold and used by professionals. Professionals should consult local regulations or work with trusted distributors familiar with these requirements.

Sourcing aesthetic injectables requires vigilance. Unauthorized channels and parallel imports can present significant risks to clinics. Products obtained through gray markets may lack proper storage, cold chain integrity, or come without verifiable batch information. This can compromise product stability and introduce regulatory non-compliance issues. For comparison, professionals should consider the sourcing integrity of products like those discussed in the Metoo Fill+ Hyaluronic Acid Dermal Filler Comparison. Ensuring product authenticity and traceability back to the manufacturer is paramount for patient safety and clinic reputation.

When procuring Chaeum Premium No. 4, professionals must demand comprehensive documentation from their suppliers. This includes:

• Certificate of Origin: Confirms the product's manufacturing country.
• Certificate of Analysis (CoA): Details the quality control tests performed on the specific batch.
• Batch Numbers and Expiration Dates: Crucial for traceability and stock management.
• Cold Chain Documentation: Proof of proper temperature-controlled storage and transport, especially vital for biological products.

Demanding these documents ensures the integrity and regulatory compliance of the Chaeum Premium No. 4 units stocked in your clinic.